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Abstract. Extended longevity is often accompanied by frailty
and increased susceptibility to a variety of crippling disorders.
One of the most striking features of human aging is sarcopenia,
which is defined as the age-related decline in skeletal muscle
mass and strength. Although various metabolic and functional
defects in aging muscle fibres have been described over the
last decade, it is not known whether a pathophysiological
hierarchy exists within degenerative pathways leading to
muscle wasting. Hence, in order to identify novel biomarkers
of age-dependent skeletal muscle degeneration, we have here
applied mass spectrometry-based proteomics for studying
global muscle protein expression patterns. As a model system
of sarcopenia, we have employed crude extracts from senescent
rat gastrocnemius muscle, as compared to young adult tissue
preparations. Using the highly sensitive protein dye Deep
Purple for the analysis of the 2-D separated muscle proteome
and peptide mass fingerprinting for the identification of
individual protein spots, a differential expression pattern was
observed for contractile proteins, metabolic factors, regulatory
components and heat shock elements. A drastic increase was
shown for αB-crystallin, myosin light chain MLC-1, phospho-
glycerate kinase, adenylate kinase, triosephosphate isomerase,
albumin, aconitase and nucleoside-diphosphate kinase in aged
fibres. In contrast, the expression of pyruvate kinase, aldolase,
creatine kinase, transferrin, α-tropomyosin and myosin light
chain MLC-3 was decreased in old skeletal muscle. Compa-
rative 2-D immunoblotting of selected candidate proteins has
confirmed the effect of aging on the skeletal muscle proteome.
These findings demonstrate a severely perturbed protein
expression pattern in aged skeletal muscle, which reflects the
underlying molecular alterations causing a drastic decline of
muscle strength in the senescent organism. In the long-term,
the systematic deduction of abnormal protein expression in
aged muscle by proteomic profiling approaches may lead to
the cataloguing of a cohort of novel therapeutic targets to
treat muscular weakness in the aging population.
Introduction
During aging, cellular alterations in the capacity to maintain
normal homeostasis play a central role in the reduced biological
function of many tissue and organ systems. The senescent
organism is predisposed to a host of pathologies including
cardiovascular disorders, cancer and neurodegenerative
diseases. Sarcopenia, the age-related decline in skeletal
muscle mass and strength, is another major complication in
the elderly (1-3). Since senescent muscle wasting is not well
understood on the molecular and cellular level, no effective
treatment has yet been developed to counteract age-related
fibre degeneration (4-6). A variety of pathogenic mechanisms
are currently being discussed that might be involved in
rendering muscles more susceptible to fiber atrophy (7).
Since skeletal muscle represents the most abundant tissue in
the body, fiber degeneration has severe consequences for
movement, posture, the overall integration of metabolism and
heat homeostasis (8).
Age-dependent muscle weakness is associated with
oxidative stress, impaired mitochondrial metabolism,
decreased microcirculation, increased apoptosis, altered post-
translational modifications of key muscle proteins, free radical
production, changed hormonal responses, a decreased re-
generative potential and impaired neuronal signal transduction
(9-15). The proposed molecular basis for abnormal triad
signaling in aged fibres is a drastic reduction in voltage-
sensing α1S-dihydropyridine receptor units at the transverse
tubules, leading to excitation-contraction uncoupling (16).
This triggers a pathophysiological increase in the percentage
of sarcoplasmic reticulum Ca2+-release channels that are
not physically coupled to the voltage-sensor (17). The
consequence is abnormal Ca2+-handling and impaired initiation
of contraction. In addition, denervation of aged fibres may
represent a key pathological insult to the motor unit system
resulting in muscular atrophy (18,19).
Since muscle degeneration is characteristic of the aging
process in humans, this warrants a detailed biochemical
analysis into the differential protein expression pattern between
young and old fibres. Proteomics, the large-scale and high-
throughput biochemical approach to study entire protein
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complements (20), suggests itself for the global identification
of complex alterations in aged tissues (21). The systematic
deduction of altered protein expression patterns during the
aging process may lead to the discovery of new therapeutic
targets to counteract sarcopenia of old age (22). Mass spectro-
metric peptide mass fingerprinting is an ideal biochemical
identification tool for the swift cataloguing of muscle proteins
involved in fibre degeneration, as recently reviewed by Doran
et al (23) and has been applied in this study.
Over the last few decades of biomedical research, both
spontaneous and genetically engineered animal models of
muscular disorders have been employed for investigating
pathophysiological processes. Skeletal muscle specimens
from inbred animal strains exhibit genetically much less
inter-individual differences as compared to patient biopsies,
therefore considerably lower experimental repeats can be
used in initial proteomic profiling exercises. Based on the
findings from comparative animal model analyses, a more
informed decision on the design of clinical studies could be
reached (24). Hence, cohorts of new biomarkers identified by
animal model proteomics can then be used for an in-depth
characterization of diseased human muscles in order to improve
diagnostic procedures or design better treatment strategies.
30-month old Wister rats represent an established animal
model of skeletal muscle aging. A variety of studies have
been performed with this inbred animal strain (16,25-27).
Since a previous proteomic study, which focused on 7 versus
18 versus 30-month old rats, demonstrated that 7-month old
muscle and 18-month old muscle exhibited similar protein
expression pattern (27), we have carried out here a comparative
profiling of young adult (3-months) versus senescent (30-
months) skeletal muscle fibres. In contrast to the 2-D gel
electrophoretic analysis based on Coomassie Brilliant Blue
R-250 by Piec et al (27), we have here employed the more
sensitive fluorescent protein dye Deep Purple for the staining
of differentially expressed muscle proteins. Epicoccone, the
active ingredient in Deep Purple total protein stain, is a novel
fluorescent compound from the fungus Epicoccum nigrum
(28,29) which is a superior protein dye as compared to non-
fluorescent probes (30). The proteomic profiling of aged
skeletal muscle fibres revealed a differential expression pattern
for metabolic enzymes, contractile elements, stress proteins
and regulatory components. These findings demonstrate that
a severely perturbed protein expression pattern is associated
with the drastic decline of muscle mass and strength in the
senescent organism.
Materials and methods
Materials. Electrophoresis grade chemicals, the 2-D Quant
kit for protein quantification, 24-cm IPG strips (pH 3.0-10),
IPG ampholytes (pH 3.0-10), fluorescent protein dye Deep
Purple stock solution and acetonitrile were purchased from
Amersham Biosciences/GE Healthcare (Little Chalfont,
Bucks., UK). Protease inhibitors were from Roche Diagnostics
(Mannheim, Germany). Ultrapure Protogel acrylamide stock
solutions were from National Diagnostics (Atlanta, GA, USA).
DNase-I enzyme was from Sigma Chemical Co. (Dorset, UK).
A matrix kit containing α-cyano-4-hydroxycinnamic acid and
an external calibration peptide mixture was obtained from
Laserbiolabs, Sophia-Antipolis, France. Sequencing grade-
modified trypsin was purchased from Promega (Madison, WI,
USA). Chemiluminescence substrate was from Pierce and
Warriner (Chester, UK) and nitrocellulose membranes were
purchased from Millipore (Bedford, MA, USA). All other
chemicals were of analytical grade and purchased from Sigma
Chemical Co.
Antibodies. Primary antibodies that recognize skeletal muscle
markers were from Abcam Ltd., Cambridge, UK (pAb ab6910
to muscle aldolase, pAb ab28760 to triosephosphate isomerase,
pAb ab9033 to transferrin); Abgent, San Diego, CA, USA
(pAb AP7094b to phosphoglycerate kinase 1, pAb ap1936c
to aconitase isoform ACO2); Abnova GmbH, Heidelberg,
Germany (mAb A412-1A3 to the muscle-specific CA3-isoform
of carbonic anhydrase); and Santa Cruz Biotechnology, Santa
Cruz, CA, USA (pAb sc-28785 to adenylate kinase isoform
AK1). Peroxidase conjugated secondary antibodies were
purchased from Chemicon International (Temecula, CA, USA).
Extraction of total muscle protein complement. As an
established animal model of sarcopenia, the gastrocnemius
muscle from 30-month old Wistar rats was dissected and
biochemically compared to young adult muscle from 3-month
old rats. Animals, which were kept at a standard light-dark
cycle and fed ad libitum, were obtained from the Animal
Facility of the Department of Physiology, Trinity College
Dublin. Freshly dissected muscle specimens were quick-
frozen in liquid nitrogen and ground into a fine powder using
a mortar and pestle. Equal quantities of 100 mg wet weight
of muscle were used for both young adult and senescent
samples. The resulting tissue powder was placed into 1 ml of
lysis buffer [7 M urea, 2 M thiourea, 20 mM Tris, 65 mM
CHAPS, 100 mM DTT and 5% (v/v) pH 3.0-10 ampholytes].
To remove DNA, 2 μl of DNase-I (200 units) were added per
100 μl of lysis buffer. In order to prevent excess degradation
of protein samples, the buffer was supplemented with a
protease inhibitor cocktail containing 1 μM leupeptin, 1.4 μM
pepstatin, 0.15 μM aprotinin, 0.5 mM soybean trypsin
inhibitor, 0.2 mM prefabloc, 0.3 μM E-64 and 1 mM EDTA
(31). Following 3 h of incubation at room temperature with
vortexing every 10 min for 30 sec, the suspension was
centrifuged for 20 min at 20,000 g. The lower layer of the
supernatant, which contains the muscle protein fraction, was
retained and samples were three times precipitated with
acetone to remove any excess salts, lipids or nucleic acids
(32). The final protein pellet was resuspended in 1 ml lysis
buffer and its concentration determined using the Amersham
2-D Quant kit.
2-D gel electrophoresis. For isoelectric focusing, IPG strips
were rehydrated for 12 h with rehydration buffer [7 M urea,
2 M thiourea, 20 mM Tris, 65 mM CHAPS, 100 mM DTT
and 5% (v/v) pH 3.0-10 ampholytes; containing 0.05% (w/v)
bromophenol blue as a tracking dye] in a re-swelling tray from
Amersham Biosciences/GE Healthcare. After re-swelling, the
IPG strips were loaded gel side up in an Amersham Ettan
IPGphor manifold and covered with 108 ml of cover fluid.
Five hundred μg of sample, either representing the total
protein complement from young adult or old skeletal muscle,
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was added by anodic cup loading to the strips and run on an
Amersham IPGphor IEF system, employing the following
running conditions: 30 V for 1 h, 100 V for 1 h, 500 V for 1 h,
1000 V for 1 h, 3000 V for 1 h, 6000 V 1 h, 8000 V for 3 h,
500 V for 4 h, and finally 8000 V for 3 h (33). Following
isoelectric focusing, IPG strips were equilibrated twice for
30 min using 6 M urea, 30% (w/v) glycerol, 2% (w/v) sodium
dodecyl sulfate, 100 mM Tris-HCl, pH 8.8, whereby the first
incubation step was performed with the addition of 100 mM
dithiothreitol and the second incubation step with 0.25 M
iodoacetamide. The strips were then briefly washed in SDS
running buffer and placed on top of 12.5% (w/v) resolving
gels and kept in place using a 1% (w/v) agarose sealing gel.
The gel electrophoretic separation of the skeletal muscle
proteome in the second dimension was carried out by standard
SDS-PAGE using an Amersham Ettan DALT-Twelve system
(34). Gels were electrophoresed for 2 h at 30 V, followed by
an 80-V step until the bromophenol blue dye front had just
ran off the gel.
Gel staining, image acquisition and 2-D image analysis.
Before staining with the fluorescent Deep Purple protein dye,
2-D gels were fixed using 7.5% (v/v) acetic acid and 10%
(v/v) methanol. Gels were then washed for 30 min with a
solution containing 35 mM sodium hydrogen carbonate and
300 mM sodium carbonate and incubated for 1 h in the dark
with a 1:200 dilution of the Deep Purple stock solution (28-30).
Following saturation with the protein dye, gels were destained
twice for 15 min using 7.5% (v/v) acetic acid. Fluorescently
labelled proteins were visualised using the Typhoon Trio
variable mode imager from Amersham Biosciences/GE
Healthcare at a scanning wavelength of λ=528 nm. The PMT
values for gels analysed were between 500 V and 580 V,
whereby scanning was performed at 100 μm resolution. 2-D
gel images were cropped using ImageQuant TL software. In
order to determine changes in protein levels, 2-D gel spot
patterns from young adult versus old skeletal muscle prepa-
rations were compared across 10 gels using ImageMaster 2-D
platinum (version 5) software. 2-D protein spots of interest
that exhibited a 1.4-fold increase or decrease in expression
were subsequently identified by MS analysis.
Mass spectrometric protein identification. In order to identify
muscle proteins that showed a changed density between
young adult and old gastrocnemius fibres, mass spectrometric
PMF analysis (35) was employed using an Ettan MALDI-ToF
Pro instrument from Amersham Biosciences. 2-D protein
spots, which had been identified on fluorescently stained
Deep Purple gels as being differentially expressed, were
excised from Colloidal Coomassie Blue-stained pick gels that
had been run in parallel in the above outlined Ettan DALT-
Twelve gel electrophoretic separation system (32). Gel plugs
were placed in 1.5 ml Eppendorf tubes which had been pre-
siliconised with Sigmacote (Sigma Chemical Co.) and were
then desalted, destained, washed, dried, digested and mixed
with matrix by an optimized procedure recently described by
our laboratory (31-34). The digestion solution contained 1 μg
trypsin per 20 μl 50 mM NH4HCO3 and was applied for 1 h
at 40˚C. The resulting peptide mixture was eluted onto
the sample plate with an equal volume of matrix solution
containing 5 mg/ml α-cyano-4-hydroxycinnamic acid in 50%
(v/v) acetonitrile/0.1% (v/v) trifluoroacetic acid. Recording
of mass spectra using the MALDI-ToF method was carried out
in the positive reflector mode, with an accelerating voltage of
20 kV and pulsed extraction on (focus mass of 2500). For
convenient internal calibration, peptide products from trypsin
autolysis activity at 221.104 m/z and 842.50 m/z were used. In
addition, external peptides were also employed for calibration
purposes. Peptidemix-1 from Laserbiolabs (Sophia-Antipolis,
France) contains suitable peaks ranging from 1046.5 m/z to
2465.10 m/z. Analysis of the mass spectra was performed
with Ettan MALDI evaluation software. For the identification
of individual protein species, the ProFound database search
engine for peptide mass fingerprints was used.
Immunoblot analysis. Proteins separated by 2-D gel electro-
phoresis, as described above in detail, were transferred to
Immobilon NC-pure nitrocellulose membranes using a
Transblot Cell from Bio-Rad Laboratories (Hemel Hempstead,
Herts., UK) at 100 V for 70 min (36). To evaluate transfer
efficiency, membrane sheets were reversibly stained with
Ponceau-S Red. Removal of dye was achieved by several
washes in 0.9% (w/v) NaCl, 50 mM sodium phosphate,
pH 7.0. Blots were then blocked for 2 h in 5% (w/v) fat-free
milk powder disolved in above phosphate-buffered saline and
then incubated in suitably diluted primary antibody for 3 h,
followed by two 10-min washes in blocking solution (37).
Subsequently, immuno-decorated proteins were incubated
with peroxidase-conjugated secondary antibody for 1 h,
washed twice for 10 min in blocking solution and twice for
10 min in phosphate-buffered saline. Antibody-labelled 2-D
protein spots were visualised by enhanced chemiluminescence
using the Pierce Supersignal ECL kit (38). To compare the
relative abundance of distinct muscle proteins in young adult
versus senescent fibres, the densitometric analysis of immuno-
decorated spots was carried out using a Molecular Dynamics
300S computing densitometer (Sunnyvale, CA, USA) with
ImageMaster v5.0 software. Statistical evaluation of immuno-
decoration was performed with Graphpad PRISM 5 software
programme (Graphpad Software Inc., San Diego, CA).
Results
2-D gel electrophoretic analysis of aging rat skeletal muscle.
In order to identify potential changes in the expression
pattern of soluble skeletal muscle proteins during aging, total
extracts from 3-month versus 30-month old rat gastrocnemius
muscle were separated by standard 2-D gel electrophoresis.
Isoelectric focusing in the first dimension was performed with
a pH 3.0 to pH 10 gradient, which was followed by sodium
dodecyl sulfate polyacrylamide gel electrophoresis covering
a molecular mass range of ~10 kDa to 220 kDa in the second
dimension. As illustrated by the two representative protein
gels in Fig. 1, the fluorescent Deep Purple total protein stain
revealed a relatively comparable overall 2-D protein spot
pattern in young adult versus old muscle fibre preparations.
The relative position of key skeletal muscle protein spots
represented in this expression profile agreed with published
results from international databanks (39-43) and our own
previous studies on normal, dystrophic and transforming
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE  20:  145-153,  2007 147
muscle fibres (31-34). Thus, for the statistical evaluation of
changes in individual protein spots, 2-D gel analysis software
was employed, followed by the mass spectrometric PMF
identification of candidate proteins.
Differential protein expression pattern in young adult versus
old rat skeletal muscle. 2-D gel spot patterns were compared
across 10 slab gels using the ImageMaster 2-D platinum
software programme. Out of ~900 clearly separated 2-D
protein spots that were recognized by Deep Purple staining,
30 spots were shown to be differentially expressed in 3-month
versus 30-month old gastrocnemius muscle (Fig. 2). 2-D
protein spots of interest that exhibited a 1.4-fold increase or
decrease in expression were identified by MS methodology.
PMF analysis using MALDI-ToF MS technology resulted
in the identification of 14 distinct protein species. Changed
muscle protein spots corresponded to αB-crystallin (pI 6.8;
20 kDa), myosin light chain 1 (pI 5; 21 kDa), phosphoglycerate
kinase 1 (pI 8.3; 45 kDa), adenylate kinase 1 (pI 7.7; 22 kDa),
Tpi1 protein (pI 7.1; 27 kDa), albumin (pI 6.1; 71 kDa)
aconitase 2 (pI 8.2; 86 kDa), nucleoside-diphosphate kinase B
(pI 6.9; 17.3 kDa), myosin light chain 3 (pI 5; 22 kDa),
α-tropomyosin (pI 4.8; 34 kDa); creatine kinase (pI 8; 33 kDa);
transferrin (pI 7; 79 kDa), aldolase A (pI 8.8; 39 kDa), and
pyruvate kinase (pI 6.6; 58 kDa). Table I summarises the
information gained from the proteomic profiling of aged
skeletal muscle fibres. The table gives detailed information
on the spot number of proteins with a changed density, so
that they can be correlated to the numbering in the 2-D master
gel of the aged skeletal muscle proteome shown in Fig. 2.
Table I lists the percentage coverage of the PMF-identified
peptide fragments with respect to the total primary muscle
protein sequence, the isoelectric point of the identified protein,
its apparent molecular mass and the fold change in density.
As can be seen in Table I, the small heat shock protein
αB-crystallin (spot 1), the contractile element myosin light
chain isoform MLC-1 (spot 2) and the enzyme phospho-
glycerate kinase 1 (spot 3) exhibited a drastic increase in
abundance. The enzyme adenylate kinase (spot 4), crucial for
nucleotide metabolism, and the triosephosphate isomerase
isoform Tpi1 (spot 5) showed both an ~1.5-fold increase in
expression. Importantly, the extracellular fatty acid transport
protein albumin (spot 6) was found to be increased, suggesting
a shift to more aerobic-oxidative metabolism in aged fibres.
In agreement, the mitochondrial citric acid cycle marker
aconitase-2 represented by 2-D spot 7 was shown to be
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Figure 1. 2-D gel electrophoretic analysis of normal versus aged skeletal
muscle extracts using fluorescent Deep Purple labelling. Shown are 2-D gel
electrophoretically separated total gastrocnemius muscle extracts from young
adult (A, 3-month old) and senescent (B, 30-month old) Wistar rats. The pH
values of the first dimension gel system and molecular mass standards (in kDa)
of the second dimension are indicated on the top and on the left of the panels,
respectively.
Figure 2. 2-D gel electrophoretic master map of the aged skeletal muscle
proteome. Shown is a 2-D master gel of the aged gastrocnemius muscle
proteome. Distinct 2-D protein spots are marked by red borders and muscle
proteins that exhibited drastic changes in their abundance are indicated with
green borders. Proteins with a drastically altered abundance, which have been
identified by mass spectrometric PMF analysis, are numbered 1-15. See
Table I for a detailed listing of density changes in αB-crystallin (pI 6.8;
20 kDa), myosin light chain 1 (pI 5; 21 kDa), phosphoglycerate kinase 1 (pI
8.3; 45 kDa), adenylate kinase 1 (pI 7.7; 22 kDa), triosephosphate isomerase
Tpi1 (pI 7.1; 27 kDa), albumin (pI 6.1; 71 kDa) aconitase 2 (pI 8.2; 86 kDa),
nucleoside-diphosphate kinase B (pI 6.9; 7.3 kDa), myosin light chain 3
(pI 5; 22 kDa), α-tropomyosin (pI 4.8; 34 kDa); creatine kinase (pI 8; 33 kDa);
transferrin (pI 7; 79 kDa), aldolase A (pI 8.8; 39 kDa), and pyruvate kinase
(pI 6.6; 58 kDa). The pH values of the first dimension gel system and
molecular mass standards (in kDa) of the second dimension are indicated on
the top and on the left of the panels, respectively.
increased in its expression. However, immuno-decoration of
the entire aconitase complement, as described below, did not
confirm that all aconitase isoforms are affected in the same
way during fibre aging. Nucleoside-diphosphate kinase
isoform NDK-B (spot 8) exhibited an increased expression.
In contrast, the contractile elements myosin light chain MLC-3
(spot 9) and α-tropomyosin (spot 10) showed a decreased
density in senescent fibres. The glycolytic enzymes aldolase A
(spot 14) and pyruvate kinase (spot 15) exhibited a drastric
2- and 2.6-fold decrease, respectively. In addition, transferrin
(spot 12) and creatine kinase (spots 11 and 13) showed an
apparent down-regulation in senescent muscle. Several un-
identified proteins exhibited an increased or decreased density
in aged fibres (Fig. 2), but MS analysis of its peptide fragments
failed to give reliable data for proper identification (data not
shown). A Deep Purple-labelled 2-D spot at position pI 6.9/
29.4 kDa was identified by PMF analysis as the muscle
isoform CA3 of carbonic anhydrase. Densitometric scanning
revealed a 4.5-fold increase, which however was not confirmed
by immunoblotting as shown below. Since the CA3-containing
spot was part of a larger elongated 2-D spot cluster, which
included other abundant muscle proteins, the densitometric
analysis lead to a false positive. This finding illustrates the
importance of confirming the results from proteomic profiling
studies based on MALDI-ToF technology, using other bio-
chemical or cell biological methods, such as immunoblotting
or immunofluorescence microscopy.
Immunoblot analysis of biomarkers of sarcopenia of old age.
To document the reliability of the comparative densitometric
analysis of 2-D spot patterns following staining with the
fluorescent dye Deep Purple and in order to confirm the
protein identification via MS-based MALDI-ToF proteomics,
we picked several representative proteins of the group of up-
and down-regulated muscle proteins for 2-D immunoblotting
studies. As illustrated in Fig. 3A-D, the increase in adenylate
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Table I. List of identified protein species that exhibit a drastic change in expression in 3-month versus 30-month old rat
gastrocnemius muscle.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Spot no. Name of identified Protein Sequence pI Molecular Fold change
protein accession no. coverage (%) mass (kDa) +/-
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
1 αB-crystallin gi|30387800| 49.0 6.8 20.15 2.45
2 Myosin light chain 1 gi|127131| 54.0 5 20.66 1.91
3 Phosphoglycerate kinase 1 gi|38649310| 33.6 8.3 44.92 1.59
4 Adenylate kinase 1 gi|23831184| 43.8 7.7 21.64 1.56
5 Triosephosphate isomerase Tpi1 gi|38512111| 23.8 7.1 27.21 1.54
6 Albumin gi|55391508| 17.0 6.1 70.74 1.47
7 Aconitase ACO2 gi|38541404| 27.6 8.2 86.16 1.46
8 Nucleoside-diphosphate kinase NDK-B gi|127984| 49.0 6.9 17.3 1.40
9 Myosin light chain 3 gi|6981240| 60.0 5 22.14 -1.39
10 α-tropomyosin gi|207352| 44.6 4.8 33.82 -1.52
11 Creatine kinase gi|203480| 23.0 8 33.43 -1.55
12 Transferrin gi|6175089| 6.6 7 78.57 -1.66
13 Creatine kinase gi|203480| 34.0 8 33.43 -1.91
14 Aldolase A gi|6978487| 30.0 8.8 39.33 -1.99
15 Pyruvate kinase gi|16757994| 18.0 6.6 57.8 -2.62
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Figure 3. 2-D immunoblot analysis of adenylate kinase and phospho-
glycerate kinase in aged skeletal muscle. Shown is the immuno-decoration
of nitrocellulose replicas of 2-D gels, as shown in Fig. 1, representing total
gastrocnemius muscle extracts from young adult (A and C, 3-month old) and
senescent (B and D, 30-month old) Wistar rats. Antibodies were directed
against adenylate kinase (A and B, AK1), and phosphoglycerate kinase (C and
D, PGK1). The comparative immunoblotting with 3-month versus 30-month
old muscle preparations was statistically evaluated using an unpaired Student's
t-test (n=5; *p<0.01; ***p<0.001) and is graphically shown in panels (E) and (F).
kinase and phosphoglycerate kinase in aged fibres was clearly
confirmed by immuno-decoration with highly specific anti-
bodies. The statistically significant differences in expression
levels (Fig. 3E and F) correlated relatively well with the
proteomic survey listed in Table I. While single protein species
were recognized in the case of the AK1 and PGK1 isoforms,
antibody labelling of triosephosphate isomerase revealed a
cohort of eight individual 2-D spots representing this essential
metabolic enzyme (Fig. 4A and B). Although the statistical
analysis of Western blotting showed no significant difference
in the abundance of these proteins between young adult and
senescent muscle fibres, the analysis indicates a trend towards
an increased expression of the TPI1 isoform in aged muscle
(Fig. 4C). The immunoblotting of mitochondrial aconitase
isoform ACO2 gave an interesting result, since it confirmed
the increase of a distinct 2-D spot representing this enzyme,
but an overall decrease of the entire immuno-decorated
aconitase complement in aged skeletal muscle (Fig. 5A and B).
Hence, the MS-identified ACO2 spot with a higher density
does not seem to be representative for the total cohort of
aconitase species in skeletal muscle (Fig. 5C and D). The
decreased abundance of transferrin and aldolase was confirmed
by immunoblotting (Fig. 6A-D) and the statistical analysis
(Fig. 6G and H) correlated relatively well with the findings
from the proteomic profiling study summarized in Table I.
Antibody labelling of the muscle-specific CA3 isoform of
carbonic anhydrase showed a decreased abundance of this
enzyme in aged fibres (Fig. 6E, F and I), therefore demon-
strating that the MS-identified CA3-spot included other more
abundant muscle proteins besides carbonic anhydrase. It is
encouraging that antibody staining confirmed the identification
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Figure 4. 2-D immunoblot analysis of triosephosphate isomerase in aged
skeletal muscle. Shown is the immuno-decoration of nitrocellulose replicas
of 2-D gels, as shown in Fig. 1, representing total gastrocnemius muscle
extracts from young adult (A, 3-month old) and senescent (B, 30-month old)
Wistar rats. Antibodies were directed against triosephosphate isomerase (A and
B, TPI1). The comparative immunoblotting with 3-month versus 30-month old
muscle preparations was statistically evaluated using an unpaired Student's
t-test (n=5; no significant difference) and is graphically shown in panel (C).
Figure 6. 2-D immunoblot analysis of transferrin, aldolase and carbonic
anhydrase in aged skeletal muscle. Shown is the immuno-decoration of
nitrocellulose replicas of 2-D gels, as shown in Fig. 1, representing total
gastrocnemius muscle extracts from young adult (A, C and E, 3-month old)
and senescent (B, D and F, 30-month old) Wistar rats. Antibodies were
directed against transferrin (A and B, TF), aldolase (C and D, ALD-A), and
the muscle-specific carbonic anhydrase (E and F, CA3). The comparative
immunoblotting with 3-month versus 30-month old muscle preparations was
statistically evaluated using an unpaired Student's t-test (n=5; *p<0.05;
**p<0.01) and is graphically shown in panels (G) to (I).
Figure 5. 2-D immunoblot analysis of aconitase in aged skeletal muscle.
Shown is the immuno-decoration of nitrocellulose replicas of 2-D gels, as
shown in Fig. 1, representing total gastrocnemius muscle extracts from
young adult (A, 3-month old) and senescent (B, 30-month old) Wistar rats.
Antibodies were directed against aconitase (A and B, ACO2). White circles
mark the MS-identified aconitase 2-D spot (see Table I) and the black
border surrounds the total cohort of ACO2-labelled protein spots. The
comparative immunoblotting with 3-month versus 30-month old muscle
preparations was statistically evaluated using an unpaired Student's t-test
(n=5; *p<0.05) and is graphically shown in panels (C) and (D).
of individual muscle proteins and that this technique was able
to clarify their change in expression levels during aging. This
demonstrates the reliability of MS protein identification
methodology and shows that the overall rate of correct
evaluation of 2-D spot density by densitometric analysis of
Deep Purpled stained 2-D gels is very high.
Discussion
The pathophysiology of sarcopenia is characterised by a
significant reduction in overall skeletal muscle mass, a
decrease in fibre strength and increased fatigability (7,8).
Sarcopenia appears to occur in most humans to some degree
as a consequence of aging, but may develop into a serious
neuromuscular pathology in senescent individuals (3). Severe
forms of sarcopenia can be accelerated by a variety of factors
including inactivity, poor nutrition and chronic illness (2). It
is estimated that from the fourth decade on, approximately
five percent of skeletal muscle mass is lost per decade (1). In
this respect, the research outlined in this project will attempt
to systematically determine abnormal protein expression
patterns in senescent muscle tissue. This might unearth new
ways to treat muscular weakness in the aging population (22).
The proteomic profiling of an animal model of sarcopenia,
30-month old gastrocnemius muscles from Wistar rats, has
clearly shown a severely disturbed protein expression pattern
in senescent fibres as compared to young adult tissue. This has
included proteins involved in stress response, the contractile
apparatus and metabolic regulation. These protein species
can now be taken as a starting point for in-depth biochemical,
cell biological and physiological characterization of aged
muscle fibres. 2-D gel electrophoresis is a highly reproducible
technique (44) and proteomic surveys usually exhibit very
few false positive or negative results (45). Hence, the
findings from proteomic profiling exercises can give reliable
trends about biological changes in pathological tissues (23)
and can be exploited in the design of future clinical studies
(24).
The cohort of biomarkers identified by the animal model
proteomic survey described here demonstrates a distinct up-
regulation of cellular stress elements. The drastic increase
of the small heat shock protein αB-crystallin in senescent
skeletal muscle suggests that age-dependent alterations in
cytoskeletal filaments are counteracted by the increase in
distinct chaperones. Small stress proteins are relatively
abundant in muscle tissues (46) and the chaperone activity
of the α-crystallin subfamily of proteins was shown to be
involved in the modulation of intermediate filament assembly
(47). Continuous contractile activity has a considerable effect
on the expression levels of αB-crystallin (48,49) making the
finding presented here an interesting observation with respect
to the mechanisms underlying fibre modifications during
aging. Since the aggregation of denatured muscle proteins
may be detrimental to the cellular homeostasis of aged fibres,
the increased presence of small heat shock proteins is probably
involved in reversing the age-related damage to skeletal
muscles. As reviewed by Nishimura and Sharp (50), heat shock
proteins play a central role in many neuromuscular diseases.
This includes x-linked Duchenne muscular dystrophy (51). It
was recently shown that the small heat shock protein cvHSP
is greatly increased in its abundance in the dystrophin-
deficient diaphragm (32). Possibly, the muscle-specific family
of low-molecular-mass stress proteins represents an important
new class of diagnostic markers and/or therapeutic targets in
common muscle disorders.
The disturbed expression pattern of tropomyosin and
myosin light chains (52), as described here, agrees with
previous proteomic studies on muscle aging (27,53). As shown
by numerous studies, the integrity of the aged motor unit is
severely impaired in aged fibres (4,5). Changes in fibre
innervation has a profound effect on the mechanical properties
of senescent fibres (18). Interestingly, denervated muscles
and aged fibre populations show many similarities, suggesting
that sarcopenia might be at least partially due to impaired
neuronal transmission (19). Since the degree of neuromuscular
activity dictates gene expression patterns in the multi-nucleated
muscle fibres belonging to a motor unit (54), pathophysio-
logical alterations in the innervating motor neuron system
will negatively affect muscle protein expression levels.
Although a metabolic shift towards more aerobic-oxidative
metabolism and slower switch characteristics are evident in
older skeletal muscles (3,7,8), the molecular alterations within
the contractile apparatus are extremely complex and do not
necessarily agree with a predominant transformation to slower
fibres (53). The proteomics findings shown here suggest
changes in glycolytic enzymes and key elements of the citric
acid cycle (55). Individual proteins belonging to the same
major metabolic pathway may be affected in a differential
way. While the expression of phosphoglycerate kinase and
triosephosphate isomerase were shown to be increased,
pyruvate kinase and aldolase levels were decreased. Since
phosphoglycerate kinase and pyruvate kinase represent two
glycolytic enzymes that are both involved in separate key
ATP-generating reactions, these results suggest complex
metabolic alterations in aged fibres. Additional more com-
prehensive investigations into the entire cohort of enzymes
responsible for glucose metabolism are necessary to
determine the exact fate of glycolytic enzymes during skeletal
muscle aging.
The recent proteomic profiling of transforming fibres has
shown a clear down-regulation of glycolytic enzymes and a
concomitant increase in the mitochondrial protein machinery
during the fast-to-slow transition process (33). In comparison,
the biochemical changes occurring in aging fibres appear
to be more complex and do not appear to reflect just fibre
transformation, but also muscular atrophy. Since the MS
identification of an up-regulated mitochondrial aconitase
isoform indicated a shift to a higher degree of aerobic-
oxidative metabolism in aged fibres, but immunoblotting
did not confirm an overall increase in the entire aconitase
complement, the transition to more oxidative metabolism
seems to be extremely complex. Decreased aconitase levels
agreed with a previous study which suggests that oxidative
damage during aging targets mitochondrial aconitase (56).
Interestingly, previous metabolic studies comparing chronic
low-frequency stimulated young versus aged fibres suggest
that both muscle types respond in a similar way to sustained
neuromuscular activity (57,58). Therefore, the age-induced
changes in glycolytic and mitochondrial enzymes might be a
consequence of altered innervation patterns and not a
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primary pathological insult within the skeletal muscle fibres
themselves.
The increased density of the extracellular fatty acid-
transporter albumin, a crucial multi-functional muscle protein
with respect to protein metabolism, fatty acid oxidation and
osmotic fibre balance (59), agrees however with a shift
towards oxidative bioenergetics in older muscle fibres. Both,
the intracellular fatty acid binding protein FABP and its
external counterpart albumin, in combination with myoglobin
levels, are believed to be limiting factors of oxidative muscle
metabolism. Therefore, the increased albumin density in the
aged skeletal muscle proteome indicates decrease anaerobic
metabolism in sarcopenia of old age. The enzymes adenylate
kinase, nucleoside diphosphate kinase and creatine kinase,
differentially affected in aged fibres, provide a major nucleotide
pathway in skeletal muscle (60,61). Alterations in their
expression profile suggest an abnormal regulation of nucleo-
tide ratios in aged fibres. Another potentially important result
with respect to muscle metabolism is the decreased expression
level of transferrin, a crucial metal ion-transporting protein.
Reduced transferrin levels may trigger pathological free
serum iron levels rendering individuals more susceptible to
infection by iron-dependent microorganisms (62).
In conclusion, although the biochemical and cellular
mechanisms that underlie sarcopenia of old age are only
beginning to be elucidated, MS-based proteomic studies into
the pathophysiological mechanisms of muscle aging might
produce novel cohorts of disease markers. Such detailed
biochemical knowledge can then be used to evaluate which
combination of neurogenic and myogenic factors determines
the destructive pathways leading to sarcopenia. Since proper
neuronal activity is a crucial factor for the maintenance of
skeletal muscle mass and strength, eliminating denervation of
aged fibres will probably be one of the most important steps
in the clinical treatment of sarcopenia. The alterations in
the expression levels of distinct classes of skeletal muscle
proteins presented in this report could be used to design
more elaborate biochemical surveys of age-induced fibre de-
generation. For example, fluorescence difference in-gel
electrophoresis (63) is several times more sensitive than
conventional proteomics (64,65). The recent difference in-gel
electrophoretic analysis of dystrophic muscle fibres exhibited
a 7-fold increase in its protein detection rate as compared to
conventional protein staining techniques (32). Hence, the
application of novel fluorescent techniques for the detection
of differential protein expression patterns in pathological
specimens may lead to improved diagnostic procedures
and/or new treatment strategies for common neuromuscular
disorders and thus improve the standard of living of a large
portion of society.
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